US Patent 11400140 Methods for treating craniosynostosis in a patient
Patent 11400140 was granted and assigned to Alexion Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Howard M. Saal0
Timothy W. Vogel0
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114001400
Date of Patent
August 2, 2022
0Patent Application Number
157712640
Date Filed
October 30, 2015
0Patent Citations
Patent Primary Examiner
Edits on 23 Apr, 2023
Golden AI
Edits on 24 Mar, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+353 characters)
US Patent 11400140 Methods for treating craniosynostosis in a patient
Article
The disclosure features methods for treating craniosynostosis in a patient (e.g., a patient having hypophosphatasia (HPP) and exhibiting or likely to have increased intracranial pressure (ICP)) by administering a soluble alkaline phosphatase (sALP) to the patient, e.g., in combination with a cranial surgery, e.g., a cranial vault remodeling procedure.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11400140
Date of patent
August 2, 2022
Patent application number
15771264
Date Filed
October 30, 2015
Patent citations
Patent primary examiner
Find more entities like US Patent 11400140 Methods for treating craniosynostosis in a patient
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.